Vertex Global HC Fund II Pte. Ltd. 13D/13G Filings for Elevation Oncology, Inc. (ELEV)

Vertex Global HC Fund II Pte. Ltd. 13D and 13G filings for Elevation Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-01-18
4:00 pm
Purchase
2021-12-31 13G Elevation Oncology, Inc.
ELEV
Vertex Global HC Fund II Pte. Ltd. 2,307,642
9.940%
2,307,642increase
(New Position)
Filing